-
Lilly Plus Kanezumab Injection Approved in China for Preventive Treatment of Adult Migraine
On January 10th, Lilly Pharmaceuticals announced that Encore&Co; Reg; Jiakanezumab Injection has officially been approved by the National Medical Products Administration for the preventive treatment ... -
Lilly Pharmaceuticals and Kanezumab Injection Approved for Preventive Treatment of Adult Migraine in China
On January 10th, Lilly Pharmaceuticals announced that Encore&Co; Reg; Jiakanezumab Injection has officially been approved by the National Medical Products Administration for the preventive treatment ... -
Sanofi responds to suspension of two flu vaccines: flu concept stocks rise for preventive measures only
Red Star Capital Bureau reported on August 27th that on the night of August 26th, major WeChat groups reported that the Pasteur influenza vaccine (trivalent and quadrivalent) under Sanofi had been su ...